4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline

C18H20N4 — CID 99837183

IUPAC4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline
SMILESCc1nccn1C[C@H]1CCCN1c1ccnc2ccccc12
InChIInChI=1S/C18H20N4/c1-14-19-10-12-21(14)13-15-5-4-11-22(15)18-8-9-20-17-7-3-2-6-16(17)18/h2-3,6-10,12,15H,4-5,11,13H2,1H3/t15-/m1/s1
InChIKeySWXLIANDUVVVFA-OAHLLOKOSA-N
MW292.39 g/mol
LogP3.41
Rot. Bonds3

About 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline

4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline (PubChem CID 99837183) has the molecular formula C18H20N4 and a molecular weight of 292.39 g/mol. Its IUPAC name is 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline.

Molecular Properties

Compound Name4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline
PubChem CID99837183
Molecular FormulaC18H20N4
Molecular Weight292.39 g/mol
Exact Mass292.17
IUPAC Name4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline
SMILESCc1nccn1C[C@H]1CCCN1c1ccnc2ccccc12
InChIInChI=1S/C18H20N4/c1-14-19-10-12-21(14)13-15-5-4-11-22(15)18-8-9-20-17-7-3-2-6-16(17)18/h2-3,6-10,12,15H,4-5,11,13H2,1H3/t15-/m1/s1
InChIKeySWXLIANDUVVVFA-OAHLLOKOSA-N
XLogP3.41
TPSA33.95 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500292.39
LogP ≤ 53.41
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinazolin-4-amine
CID 100692267
2-methyl-3-[(2S)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoxaline
CID 100692414
N-methyl-1-(1-quinolin-4-ylpyrrolidin-2-yl)methanamine
CID 62585638
(1-quinolin-4-ylpiperidin-2-yl)methanol
CID 61339741
5-methyl-2-[2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]pyrimidine
CID 133403923
N-benzyl-4-[2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]pyridine-2-carboxamide
CID 133428943
6-[2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]pyridine-2-carboxylic acid
CID 122048644
2-[(1-quinolin-4-ylpyrrolidin-2-yl)methyl]-5,6,7,8-tetrahydrocinnolin-3-one
CID 126924815
4-[(3R)-3-[1-(cyclopropylmethyl)imidazol-2-yl]piperidin-1-yl]quinoline
CID 96574055
4-[3-[1-(cyclopropylmethyl)imidazol-2-yl]piperidin-1-yl]quinoline
CID 70726995
4-ethyl-5-fluoro-6-[2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]pyrimidine
CID 75438009
N-methyl-6-[(2S)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]pyridine-3-sulfonamide
CID 100691756

Frequently Asked Questions

What is the IUPAC name of 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline?
The IUPAC name of 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline (CID 99837183) is 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline.
What is the SMILES notation for 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline?
The canonical SMILES for 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline is Cc1nccn1C[C@H]1CCCN1c1ccnc2ccccc12.
What is the InChIKey of 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline?
The InChIKey is SWXLIANDUVVVFA-OAHLLOKOSA-N. The full InChI is InChI=1S/C18H20N4/c1-14-19-10-12-21(14)13-15-5-4-11-22(15)18-8-9-20-17-7-3-2-6-16(17)18/h2-3,6-10,12,15H,4-5,11,13H2,1H3/t15-/m1/s1.
What are the key properties of 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline?
4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline has a molecular weight of 292.39 g/mol, XLogP of 3.41, 3 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(2R)-2-[(2-methylimidazol-1-yl)methyl]pyrrolidin-1-yl]quinoline is sourced from PubChem (CID 99837183), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).